Skip to main content

NYSE · Holders

Eli Lilly & Co. (LLY) Institutional Ownership & Insider Trading History

Top LLY institutional positions and insider transactions, with filters for buys, sales, option exercises, gifts, and tax withholding.

Last confirmed price
$1,284+0.84%
Oct 26, 2026, 9:49 AM EDT · Prices may be delayed

Data dates

Prices as of Oct 26, 9:49 AM EDT · Fundamentals checked Oct 26, 9:07 AM EDT · Statement period ended Jun 30, 2026

Ownership read

LLY insider transaction activity: Net selling.

Lilly Endowment, Inc is the largest institutional holder. 29 classified sales and 0 classified purchases appear in the recent insider records. 14 transactions lack a reliable action code. Use the filters below to separate open-market activity from option exercises, gifts, awards, and tax withholding.

Insider flow

LLY

Purchases0
Sales2.67M

Directional bars ignore awards, gifts, conversions, and tax withholding rows.

Top holder

90.07M

Lilly Endowment, Inc

Insider transaction activity

Net selling

$2.66B sold / $0.0000 bought · 14 unclassified

Observations shown

130

10 holder / 120 insider

Increased / initiated
Unavailable
Prior positions were not supplied
Insider rows
120
Transaction dates shown per row

Ownership concentration and transaction activity

Top 10 reported holders
Position dates differ
Changes with share-count history
Prior-position data unavailable
New / exited positions
Prior-position data unavailable
Largest increase with share-count history
Prior share counts unavailable

These changes cover the holders shown. A holder missing from this list may still own shares. Compare positions from the same reporting quarters.

Net shares sold: 2,669,170

Classified sale shares minus classified purchase shares in this sample. Includes disclosed plans and unknown plan status; excludes grants, gifts, exercises and withholding. This is activity, not sentiment.

  • Grant: 71
  • Gift: 6
  • Purchase / sale; plan unknown: 29
  • Other / unclassified: 14

Top 10 institutional holders

Eli Lilly & Co. (LLY) institutional ownership

Ranked by reported share count. Position dates and filing dates are separate when the provider supplies both.

Source: Yahoo Finance. A position date is not a filing date. View current provider table. To check a manager's 13F, search its name in SEC EDGAR; a search result is not a verified match to a row here.

Eli Lilly & Co. (LLY) institutional ownership
#Institution% heldSharesPosition date
1
Lilly Endowment, Inc
9.57%90.07MPosition as of Sep 30, 2026
2
Blackrock Inc.
7.17%67.54MPosition as of Jun 30, 2026
3
Vanguard Capital Management LLC
5.69%53.53MPosition as of Jun 30, 2026
4
PNC Financial Services Group, Inc.
5.45%51.32MPosition as of Jun 30, 2026
5
State Street Corporation
3.85%36.22MPosition as of Jun 30, 2026
6
FMR, LLC
3.02%28.46MPosition as of Jun 30, 2026
7
Capital Research Global Investors
2.22%20.87MPosition as of Jun 30, 2026
8
Vanguard Portfolio Management LLC
2.22%20.86MPosition as of Jun 30, 2026
9
Geode Capital Management, LLC
2.16%20.31MPosition as of Jun 30, 2026
10
Morgan Stanley
1.72%16.23MPosition as of Jun 30, 2026
Showing 10 of 10 matching institutional rows.

Recent insider transactions

Eli Lilly & Co. (LLY) insider transactions

Provider action descriptions keep buys and sales separate from awards, gifts, conversions, and tax withholding. Transaction window: Oct 20, 2025–Oct 19, 2026 · 120 records.

Source: Yahoo Finance. Transaction dates are not filing dates; original filing links appear only when the provider identifies a specific filing. View current provider table. Browse issuer SEC ownership filings; this lookup is not a match to each row.

Eli Lilly & Co. (LLY) insider transactions
#Insider% companyActionSharesPriceValueTransaction date
1
SULZBERGER GABRIELLE
Director
<0.01%Award / grantAward, grant, or acquisition under an equity compensation plan.
Transaction context
Classification:
Grant
10b5-1:
Not reported
Holdings after:
Not reported
Position sold:
Not calculable

Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership.

3$1,653$4,958Oct 19, 2026
2
LUCIANO JUAN R
Director
<0.01%Award / grantAward, grant, or acquisition under an equity compensation plan.
Transaction context
Classification:
Grant
10b5-1:
Not reported
Holdings after:
Not reported
Position sold:
Not calculable

Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership.

12$1,326$15,917Oct 19, 2026
3
ALVAREZ RALPH
Director
<0.01%Award / grantAward, grant, or acquisition under an equity compensation plan.
Transaction context
Classification:
Grant
10b5-1:
Not reported
Holdings after:
Not reported
Position sold:
Not calculable

Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership.

10$1,242$12,417Oct 19, 2026
4
FYRWALD J. ERIK
Director
<0.01%Award / grantAward, grant, or acquisition under an equity compensation plan.
Transaction context
Classification:
Grant
10b5-1:
Not reported
Holdings after:
Not reported
Position sold:
Not calculable

Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership.

7$1,417$9,917Oct 19, 2026
5
SULZBERGER GABRIELLE
Director
<0.01%Award / grantAward, grant, or acquisition under an equity compensation plan.
Transaction context
Classification:
Grant
10b5-1:
Not reported
Holdings after:
Not reported
Position sold:
Not calculable

Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership.

4$1,240$4,958Sep 21, 2026
6
LUCIANO JUAN R
Director
<0.01%Award / grantAward, grant, or acquisition under an equity compensation plan.
Transaction context
Classification:
Grant
10b5-1:
Not reported
Holdings after:
Not reported
Position sold:
Not calculable

Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership.

13$1,224$15,917Sep 21, 2026
7
ALVAREZ RALPH
Director
<0.01%Award / grantAward, grant, or acquisition under an equity compensation plan.
Transaction context
Classification:
Grant
10b5-1:
Not reported
Holdings after:
Not reported
Position sold:
Not calculable

Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership.

10$1,242$12,417Sep 21, 2026
8
FYRWALD J. ERIK
Director
<0.01%Award / grantAward, grant, or acquisition under an equity compensation plan.
Transaction context
Classification:
Grant
10b5-1:
Not reported
Holdings after:
Not reported
Position sold:
Not calculable

Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership.

8$1,240$9,917Sep 21, 2026
9
SEYMOUR MELISSA
Officer
<0.01%GiftGift transfer. Usually non-cash and not an open-market sale.
Transaction context
Classification:
Gift
10b5-1:
Not reported
Holdings after:
Not reported
Position sold:
Not calculable

Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership.

29Non-cashNon-cashSep 9, 2026
10
HERNANDEZ EDGARDO
Officer
<0.01%GiftGift transfer. Usually non-cash and not an open-market sale.
Transaction context
Classification:
Gift
10b5-1:
Not reported
Holdings after:
Not reported
Position sold:
Not calculable

Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership.

13Non-cashNon-cashSep 2, 2026
11
DOZIER ERIC
Officer
<0.01%GiftGift transfer. Usually non-cash and not an open-market sale.
Transaction context
Classification:
Gift
10b5-1:
Not reported
Holdings after:
Not reported
Position sold:
Not calculable

Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership.

216Non-cashNon-cashSep 2, 2026
12
SULZBERGER GABRIELLE
Director
<0.01%Award / grantAward, grant, or acquisition under an equity compensation plan.
Transaction context
Classification:
Grant
10b5-1:
Not reported
Holdings after:
Not reported
Position sold:
Not calculable

Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership.

4$1,240$4,958Aug 17, 2026
Showing 12 of 120 matching insider rows. Percent of company uses current shares outstanding.

Frequently asked

Questions about this quote

Who are the largest LLY shareholders?

Lilly Endowment, Inc is the largest reported institutional holder of LLY, with 90.07 million shares, or about 9.57% of shares outstanding.

What do the reported institutional positions show for LLY?

Eli Lilly & Co. has 10 institutional rows on file; the latest displayed position date is Sep 30, 2026. Previous position sizes are unavailable, so increases and reductions cannot be determined.

What insider transactions are available for LLY?

TECHi shows 120 dated LLY insider transactions through Oct 19, 2026, with transaction types kept separate so administrative actions are not presented as open-market trades.

Are LLY insiders buying or selling?

The displayed LLY activity reads Net selling: 29 sales and 0 purchases. Other transaction types remain separate.

Who is the most active reported LLY insider?

LILLY ENDOWMENT, INC. has the largest absolute share movement in the displayed LLY insider rows, totaling 2.65 million shares. The action labels provide the transaction context.

What this page answers

Check who owns the float and whether insiders are active.

Explore Institutional concentration, insider transaction pattern, and float context.

Keep in mind Filings are delayed or transactions are administrative rather than economic.

Browse all companies and funds

Data sources: Financial Modeling Prep · Finnhub · SEC Companyfacts · Yahoo Finance

Market data is for information only and is not trading advice. Prices and fundamentals may be delayed, reflect an earlier observation, be incomplete, or be revised. Read the data methodology or the full disclaimer.
Research tools
Regular session

Regular hours: 9:30 AM–4:00 PM America/New_York

Next open: 2026-10-27 · 9:30 AM America/New_York

Exchange calendar includes scheduled holidays and early closes. Extended-session prices appear separately only when supplied by the quote source.